Showcases advanced biotech AI hardware and software solutions that automate lab tasks, boosting research efficiency and precision for scientists.
Biotechnology
Laboratory Equipment
Artificial Intelligence
Clockwork Bio is an AI-native drug discovery company automating pre-clinical oncology research. Engineering a world without cancer.
Biotechnology
Artificial Intelligence
Drug Discovery
We are advancing next-gen dual-payload ADCs with unique payload and linker tech to deliver dual agents to tumor cells, maximizing benefits for cancer patients.
Pharmaceuticals
Biotechnology
Drug Discovery
Promising New Treatment for Drug-Resistant Epilepsy A normal, productive life is out of reach for most people with drug-resistant epilepsy. We’re here to.
Drug Discovery
Health Care
Pharmaceuticals
Our team has extensive expertise in kidney disease, targeted delivery of RNA therapeutics, translational systems biology and data sciences, translational biology, chemistry, DMPK and pharmacology.
Pharmaceuticals
Biotechnology
Drug Discovery
We have created a new class of antibody-regulated protein therapeutics activated only at disease sites, advancing cancer care and exploring broader indications.
Pharmaceuticals
Biotechnology
Drug Discovery
Targeted therapies for rare lung diseases. About Us Avalyn is a clinical-stage biotech company developing inhaled therapies to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases.
Biopharma
Drug Discovery
Pharmaceuticals
GCP
Pioneering the development of bioprinted tissue therapeutics to transform how we treat some of the most elusive diseases.
Cell & Gene Therapy
Biotechnology
Regenerative Medicine
Google Workspace
Antibodies Transformed. A revolutionary class of computationally designed biologics engineered to unlock challenging pathways and better treat disease.
Biotechnology
Drug Discovery
What's AltPep?. We are a group of innovators working to transform the diagnosis and treatment of amyloid diseases, enabling action earlier than ever thought possible. Our lead programs focus on Alzheimer's and Parkinson's diseases, with other amyloid diseases on the horizon.
Biotechnology
Diagnostics
Drug Discovery
Alpenglow Biosciences provides the Aurora 3D spatial biology platform, including the 3Di HOTLS microscope, 3D histology services, AI-powered analysis, digital pathology, spatial profiling, and quantitative tissue analysis for pharma, biotech, academia, and translational research.
Biotechnology
Bioinformatics
Laboratory Equipment
Accipiter Biosciences designs de novo, multifunctional protein biologics to treat complex diseases through advanced computational protein design.
Biotechnology
Drug Discovery
First-in-Class Active Immunotherapies that overcome immune tolerance to treat cancer and chronic infection.
Pharmaceuticals
Biotechnology
Drug Discovery
MEASURING, PREDICTING, ANDENGINEERING PROTEIN INTERACTIONS at Scale. A-Alpha Bio harnesses synthetic biology and machine learning to precisely engineer high-impact medicines.
Biotechnology
Drug Discovery
Synthetic Biology
RegCell is a Japan-based biotechnology company spun out of university research that develops novel immunotherapies focused on T cells. The company advances platform technologies to control antigen-specific T‑cell function and to harness regulatory and effector T‑cell mechanisms for therapeutic use. RegCell commercializes research led by immunologists Shimon Sakaguchi and Hiroshi Kawamoto to address clinical needs in oncology, autoimmune disease and transplantation through partnerships with pharmaceutical and clinical research organizations.
Biotechnology
Cell & Gene Therapy
Drug Discovery
REPROCELL develops and supplies human iPSC-derived cells, primary human biospecimens and related cell-based tools for research and drug discovery. The company offers preclinical assay services using fresh human tissues, molecular and assay development services, and contract research to support drug discovery and regenerative medicine programs. Founded in 2003 with operations and partnerships across the United States, United Kingdom, India and Japan, REPROCELL serves pharmaceutical, biotech and academic customers worldwide.
Biotechnology
Cell & Gene Therapy
Drug Discovery
Regional Fish Institute is an academic spin-out from Kyoto University that develops genome-edited fish and full-cycle land-based aquaculture technologies to dramatically shorten breed improvement timelines. Its commercial products include genome-edited sea bream and tiger puffer, which are the first and only genome-edited animal foods commercially marketed in the world. The company is advancing more than 20 breeding pipelines and promotes smart land aquaculture through an open-innovation network of over 70 academic and corporate partners, serving domestic and international seafood and aquaculture markets.
Farming & Agriculture
Biotechnology
Aquaculture
Rege Nephro is a Japanese biotechnology company developing cell therapies to treat chronic kidney disease using nephron progenitor cells differentiated from induced pluripotent stem (iPS) cells. It is developing nephron progenitor cell-based regenerative products intended to restore nephron function and reduce or eliminate patients' dependence on dialysis. The company targets the large chronic kidney disease patient population in Japan and internationally, aiming to offer a curative alternative to lifelong dialysis through advanced regenerative medicine.
Biotechnology
Regenerative Medicine
Cell & Gene Therapy
Euglena is a Japanese biotechnology company that pioneered outdoor mass cultivation of the microalga Euglena and converts its biomass into commercial products. It operates a health and nutrition business that markets functional foods, supplements and cosmetics containing Euglena biomass to consumers and corporate clients in Japan and abroad. The company also pursues energy and environmental businesses, conducting R&D and collaborations to develop biofuels and sustainable technologies derived from microalgae.
Bioenergy
Dietary Supplements
Biotechnology
Metcela is a Japanese pre-clinical stage biotechnology company developing cell therapies for heart failure. The company is developing a clinically oriented cell therapy product called VCF intended to treat chronic heart failure. It aims to address the increasing burden of heart failure driven by aging and lifestyle diseases by delivering a regenerative alternative to current symptomatic treatments.
Biotechnology
Regenerative Medicine
Cell & Gene Therapy
Metagen Therapeutics is a Japanese biotech startup founded by researchers from Juntendo University, Keio University and Tokyo Institute of Technology that focuses on microbiome science. It discovers and develops intestinal microbiome‑based therapeutics and drug candidates targeting various diseases through microbiome analysis and translational research. Its products and programs target clinical and pharmaceutical markets with the goal of creating social impact by improving medical care and advancing drug discovery.
Biotechnology
Drug Discovery
Microbiome
Metabologenomics is a joint venture founded by researchers from Keio University and Tokyo Institute of Technology that develops gut-environment assessment tools to enable personalized gut design aimed at disease prevention. It analyzes individuals' stool samples using its proprietary Metabologenomics technique to profile the gut environment and support stratified healthcare and medical care based on gut environment types. In May 2019 the company launched a Next-Generation Gut Environment Assessment Service for corporate and clinical customers using an original stool sampling kit.
Biotechnology
Digital Health
Genomics
Megakaryon develops platelet products manufactured from induced pluripotent stem (iPS) cells to provide a stable, donation-independent source for transfusion medicine. The company engineers protocols and scalable manufacturing techniques to produce safe, low-cost platelets for clinical transfusion and related cell-therapeutic applications. Megakaryon collaborates with academic institutions and industry partners to advance clinical translation and supply hospitals and blood services domestically and internationally.
Biotechnology
Pharmaceuticals
Cell & Gene Therapy
MUSCA is a Japanese insect-technology company that operates a biomass-recycling platform using selectively bred houseflies to convert organic waste and manure into usable products. The company uses housefly strains bred over many generations and a proprietary 100% biomass recycling system to produce organic animal feed and plant fertilizer. MUSCA collaborates with Japanese universities to validate product performance and aims to commercialize industrial-scale closed-ecological systems for agriculture and waste management.
Farming & Agriculture
Waste Management
Agricultural Biotechnology
Alivexis is a technology-driven drug discovery company developing small-molecule therapeutics for oncology, chronic inflammation and immune disorders, and rare genetic diseases. The company integrates unique core biology insights with a supercomputer-powered discovery platform and scalable networked operations to advance its proprietary programs and collaborative projects. It operates offices in Tokyo and Boston and focuses on efficient delivery of breakthrough medicines for patients with unmet medical needs.
Biotechnology
Pharmaceuticals
Drug Discovery
Braizon Therapeutics develops biopharmaceutical therapeutics, focusing on innovative biologics and targeted treatments for oncology and other serious diseases. The company applies proprietary antibody engineering and drug-delivery platforms to generate therapeutic candidates and advance them through preclinical and clinical development. Braizon targets global pharmaceutical and healthcare markets through direct development, strategic partnerships, and licensing collaborations.
Biotechnology
Pharmaceuticals
Drug Discovery
VLP Therapeutics Japan is a Tokyo-based subsidiary of US-based VLP Therapeutics that was founded in 2020 by Dr. Wataru Akahata. The company conducts research and development of novel COVID-19 vaccines using VLP Therapeutics' proprietary self-amplifying (replicon) RNA technology to design and produce vaccine candidates. It operates in the Japanese and international infectious disease vaccine market and collaborates with research and funding agencies such as the Japan Agency for Medical Research and Development (AMED) to advance preclinical and clinical development.
Biotechnology
Pharmaceuticals
Vaccines
BIOME collects distribution data on living organisms worldwide and operates a business platform for biodiversity markets. It developed an AI system that can identify the names of nearly all species and provides a smartphone app that lets users identify organisms and virtually collect them in a game-like experience. The company serves researchers, conservation organizations, citizen scientists and businesses engaged in biodiversity monitoring, conservation and environmental market services.
Data & Analytics
Environmental Biotechnology
Artificial Intelligence
Nanoegg Research Laboratories is a Japanese research spinoff from a medical university that specializes in dermatological science and drug-delivery technology. It develops proprietary delivery materials such as Nanocube and Moisturecube and commercializes pharmaceuticals, functional cosmetics, cosmetic materials and research reagents. The company markets skincare lines including the firming Horei, brightening Siroe White and MediQOL products formulated for sensitive and recurrent skin conditions, serving medical, cosmetic and research markets in Japan and internationally.
Drug Discovery
Pharmaceuticals
Cosmetics & Makeup
NAGASUNA MAYU develops novel materials derived from silk cocoons by combining traditional Japanese silk processing techniques with its own proprietary technologies. It creates silk-derived biomaterials and functional ingredients targeted at medical, industrial and food applications. By leveraging heritage silk know-how and new processing methods, NAGASUNA MAYU aims to commercialize sustainable, multifunctional silk-based materials to improve daily life and support various industries.
Biotechnology
Advanced Materials
Biomaterials
ThinkCyte develops single-cell analysis technologies that combine advanced optics, machine learning and biotechnology to support life-science research, diagnostics and therapeutics. It commercializes Ghost Cytometry, a high-throughput fluorescence image-based cell-sorting platform that enables rapid, image-informed sorting and characterization of cells. The company targets research institutions, diagnostic developers and cell-therapy manufacturers seeking high-speed, image-based cytometry and sorting solutions.
Laboratory Equipment
Diagnostics
Bioinformatics
Genomelink operates a personal DNA cloud where people upload and store raw consumer genotyping data to receive trait and ancestry insights, discover related products, and contribute to research. The company provides consumer-facing reports and developer APIs that derive phenotype and ancestry information from uploaded 23andMe/Ancestry-style raw data and offers services to researchers and biotech partners. Genomelink is active in the US and Japan startup ecosystems, has participated in accelerators including Berkeley SkyDeck and StartX, and has been featured in Japan's METI J-Startup program.
Data & Analytics
Biotechnology
Genomics
SyntheticGestalt is an AI startup that develops autonomous discovery systems to mass-produce valuable discoveries for the life sciences sector. It builds machine learning models to identify candidate drug compounds and design enzymes with novel functions, supporting drug discovery and protein engineering workflows. Founded in 2018 with offices in Tokyo and London, its team includes many PhD scientists and engineers from top UK universities and it participates in Japan's METI J-Startup program.
Artificial Intelligence
Drug Discovery
Machine Learning
Cyfuse Biomedical develops Bio-3D printing technologies and instruments for regenerative medicine, best known for its Regenova Bio-3D Printer and the Kenzan spheroid-based bioprinting method. The company manufactures scaffold-free, cell-assembled tissue constructs by fusing multicellular spheroids to create transplantable tissues and in vitro models for drug discovery and research. Cyfuse primarily serves academic, clinical and commercial research customers worldwide from its headquarters in Tokyo, Japan.
Biotechnology
3D Printing
Regenerative Medicine
Human Life CORD is a clinical-stage Japanese biotechnology company that develops off-the-shelf umbilical cord-derived allogeneic cell therapies. Its pipeline includes genetically unmodified mesenchymal stromal cell products intended to treat a range of indications from incurable disorders to aging-related diseases. The company focuses on using domestically sourced umbilical cord tissue to scale manufacturing, ensure quality and availability, and advance the next evolution of cellular medicine for an aging population.
Biotechnology
Regenerative Medicine
Cell & Gene Therapy
Gellycle develops proprietary hydrogel technology called TetraGel, a biocompatible soft material engineered for precise control over physical properties to enable applications in biological systems. Using a platform business model, the company is developing a pipeline of medical products including hemostatic agents, anti-adhesion materials and nerve-regeneration scaffolds, and has extended its hydrogel applications into industrial and agricultural markets. Gellycle positions itself as a pioneer in high-performance soft materials for medical engineering and biotechnology, aiming to replace hard materials with adaptable gels across clinical and commercial use cases.
Advanced Materials
Medical Devices
Biomaterials
Cellusion develops regenerative medicine therapies using induced pluripotent stem (iPS) cells focused on treating corneal endothelial diseases. The company is developing a proprietary minimally invasive cell therapy composed of corneal endothelial cells derived from iPS cells to reduce reliance on donor corneas and highly skilled surgeons. Its product targets patients with corneal blindness worldwide by enabling broader access to transplantation-like treatment options.
Health Care
Cell & Gene Therapy
Regenerative Medicine
Luxna Biotech is a preclinical-stage Japanese biotechnology company that develops antisense oligonucleotide (ASO) therapeutics using novel modified nucleoside chemistries and an original drug discovery platform called LuxiAPT. It leverages modified nucleosides invented at Osaka University alongside the LuxiAPT platform to discover and co-develop ASO drugs in collaboration with pharmaceutical companies and academic laboratories across multiple disease targets. The company places particular emphasis on neurological disorders and is pursuing both in-house programs and partnerships to develop therapies for spinal cord injury.
Pharmaceuticals
Drug Discovery
Biotechnology
LUCA Science is a preclinical-stage biopharmaceutical company developing a new class of mitochondrial therapies designed to restore cellular bioenergetics. It is building a platform to manufacture, store and deliver mitochondria-based drug candidates and related products for research and therapeutic development. The company targets a broad range of diseases with high unmet medical need in which mitochondrial dysfunction contributes to pathology.
Biopharma
Drug Discovery
Biotechnology
Logomix is a Japan-based synthetic biology company that develops genome engineering technologies for human cells. Its Geno-Writing platform enables precise engineering of megabase-scale genomic sequences directly within human cells, allowing creation of super-functionalized cells. Logomix positions these engineered cells for applications in cell therapy, regenerative medicine and other future cell-based therapeutics.
Regenerative Medicine
Cell & Gene Therapy
Synthetic Biology
AI SILK develops sustainable silk-like biomaterials by combining biotechnology and computational design. It engineers recombinant silk proteins and offers scalable production processes and material formulations for textiles, high-performance fibers and biomedical applications. AI SILK serves textile manufacturers, performance materials companies and medical device developers seeking biodegradable, high-strength alternatives to conventional synthetic fibers.
Textiles
Advanced Materials
Biomaterials
iHeart Japan develops allogeneic regenerative medical products derived from human induced pluripotent stem (iPS) cells targeting heart failure. It also provides in vitro research tools and cardiomyocyte platforms for cardiotoxicity screening and efficacy testing to pharmaceutical and biotechnology customers. The company aims to realize regenerative therapies that reduce reliance on heart transplantation and improve outcomes for patients with severe cardiac disease.
Regenerative Medicine
Biotechnology
Health Care
From prediction to disease-level simulation. Building organism-level models that simulate intervention response and drive high-value oncology decisions.
Medical AI
Biotechnology
Health Care
AWS
CI/CD
Docker
Go
Kubernetes
Snyk
Terraform
Unreal Engine
+22 More
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace's mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 5,800 people across 43 countries.
CRO & CDMO Services
Clinical Research
Health Care
At Mallinckrodt, we use strategic vision and employee-driven momentum to pursue a powerful mission: Listening for needs and delivering solutions. As a leader in specialty pharmaceuticals, we develop, manufacture, market and distribute innovative treatments for underserved patient populations within neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; cultured skin substitutes and gastrointestinal products. . Our expertise also extends into acute and critical care hospital products, as well as our broad portfolio of generic prescription medicines and active pharmaceutical ingredients.
Pharmaceuticals
Biopharma
Biotechnology
Beacon's AI platform for brain data enables and accelerates new treatments that transform the lives of patients with neurological and psychiatric disease. Through FDA-cleared EEG wearables, novel machine learning algorithms, enormous datasets, and advances in software engineering, we are changing the way patients are treated for disorders of the brain.
Genomics
Medical AI
Biotechnology
Python
Snowflake
SQL
Kubernetes
TypeScript
Git
Kotlin
React Native
+33 More
7
open jobs
$140k – $210k
Salary
2019
Founded
Angitia is a clinical-stage biotechnology company focused on discovering and developing breakthrough therapeutics that address the key unmet medical needs of serious musculoskeletal diseases. With the team's experience and scientific expertise in new drug development, Angitia is dedicated to bringing innovative therapeutics to help patients in need.
Biopharma
Drug Discovery
Biotechnology
MMS Holdings (MMS) is an award-winning, data-focused clinical research organization (CRO) that supports the pharmaceutical and biotech industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience, an 18-year track record, AI technology-enabled services, and a data-driven approach to drug development make MMS a valuable CRO partner. With a global footprint across four continents, MMS maintains an industry-leading customer satisfaction rating.
Pharmaceuticals
Clinical Research
CRO & CDMO Services
OpenSpecimen is a highly configurable biobanking LIMS platform used in 90+ clinical research centers across 20+ countries, leading institutions like Johns Hopkins, Oxford, Cambridge, Weill Cornell, and so forth.
Clinical Research
Laboratory Equipment
Bioinformatics
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases. We are focused on the development of proprietary therapeutics using a recently developed biological tool known as the CRISPR/Cas9 system. The promise of the CRISPR/Cas9 system is the driving force behind the creation of Intellia.
Genomics
Cell & Gene Therapy
Biotechnology
AWS
CI/CD
MuleSoft
Vault
Azure
GCP
ETL/ELT
GDPR
+4 More
3
open jobs
$229k – $390k
Salary
Viome was founded in 2016 with a mission to make illness optional by predicting and preventing chronic diseases through a deeper understanding of an individual's biology at a molecular level. Viome is the industry's only direct-to-consumer healthc...
Personalized Medicine
Molecular Diagnostics
Microbiome
AWS
Claude
Grafana
Kubernetes
MySQL
PostgreSQL
Python
Terraform
+21 More
2
open jobs
$150k – $180k
Salary
About Repligen Our mission is to inspire advances in bioprocessing as a trusted partner in the production of biologic drugs that improve human health worldwide. Repligen is a bioprocessing-focused life sciences company bringing expertise and innovation to our customers since 1981.
Laboratory Equipment
Biotechnology
Bioprocessing
.NET
Docker
Git
Jira
PostgreSQL
Rest API
SQL
JavaScript
+34 More
11
open jobs
$104k – $180k
Salary
501-1000
Team size
1981
Founded
Biotechnology
Science & Engineering
Civil & Structural Engineering
Clario is a healthcare technology company headquartered in Philadelphia, Pennsylvania, with a history dating back to 1972. The organization provides clinical trial endpoint technology and services, including electronic clinical outcome assessments, medical imaging, cardiac safety monitoring, and respiratory solutions. It operates on a global scale, supporting pharmaceutical and biotechnology firms through all phases of clinical research to generate high-quality evidence for regulatory submissions.
Medical AI
Artificial Intelligence
Biotechnology
Digital Health
Cypress
Java
Playwright
Python
Selenium
SQL
.NET
CI/CD
+73 More
26
open jobs
1001-5000
Team size
1972
Founded
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Biotechnology
Financial Services
Venture Capital
CI/CD
Databricks
Git
pySpark
Python
SQL
Terraform
Spark
+4 More
2
open jobs
201-500
Team size
1999
Founded
World-leading biometrics expertise with innovative and flexible delivery to accelerate your clinical development programme.
CRO & CDMO Services
Health Care
Clinical Research
Ellison Medical Institute. The Ellison Medical Institute strives to spark innovation, leverage technology, and drive interdisciplinary, patient-centered research to continually enhance health, reimagine and redefine cancer care, and transform lives.
Drug Discovery
Health Care
Clinical Research
JavaScript
LLM
React.js
TypeScript
CI/CD
Terraform
Kubernetes
Python
+54 More
15
open jobs
2016
Founded
Flagship Pioneering is a life sciences venture creation and platform investment firm headquartered in Cambridge, Massachusetts. Founded in 2000 by CEO Noubar Afeyan, the firm operates on a novel institutional innovation model where it acts as a principal founder, funder, and operator of first-in-category biotechnology and sustainability companies.
Biotechnology
Financial Services
Venture Capital
AWS
CI/CD
LLM
Python
TypeScript
Fine-tuning
LangGraph
PyTorch
+90 More
38
open jobs
$94k – $400k
Salary
501-1000
Team size
2000
Founded
ProPharma Group is a regulatory and compliance services company headquartered in Raleigh, North Carolina, and founded in 2001. The company provides pharmacovigilance, medical information call centres, regulatory affairs, quality assurance, and clinical research consulting to pharmaceutical, biotechnology, and medical device sponsors. It operates as a research consulting organisation rather than a trial running CRO, supporting products from development through post-market surveillance worldwide.
Security Compliance
Cybersecurity
CRO & CDMO Services
Biotechnology
SQL
AWS
Kubernetes
Python
Jira
Power BI
GCP
ISO 27001
+8 More
7
open jobs
501-1000
Team size
2001
Founded
Who We Are Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities.
CRO & CDMO Services
Health Care
Clinical Research
